Skip to main content
Fig. 1 | Experimental Hematology & Oncology

Fig. 1

From: Histological verification of the treatment effect of tirabrutinib for relapsed/refractory primary central nervous system lymphoma

Fig. 1

Histological findings of brain biopsied samples of the initial lesion and that after tirabrutinib treatment are shown. The initial lesion was diagnosed as diffuse large B cell lymphoma (DLBCL), as shown in hematoxylin and eosin stain (a). Histological appearance of an autopsied specimen of the lesion after tirabrutinib treatment showed no evidence of viable cells (Lower-right: Overview of the investigated tissue) (b)

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us